[HTML][HTML] CircGSAP regulates the cell cycle of pulmonary microvascular endothelial cells via the miR-942-5p sponge in pulmonary hypertension
Y Sun, W Wu, Q Zhao, R Jiang, J Li, L Wang… - Frontiers in Cell and …, 2022 - frontiersin.org
Background We recently demonstrated that circGSAP was diminished in lung tissues from
patients with pulmonary arterial hypertension and in hypoxia-induced pulmonary …
patients with pulmonary arterial hypertension and in hypoxia-induced pulmonary …
CEACAM6 as a Novel Therapeutic Target to Boost HO-1—mediated Antioxidant Defense in COPD
CY Wu, A Cilic, O Pak, RC Dartsch… - American Journal of …, 2023 - atsjournals.org
Rationale: Tobacco smoking and air pollution are primary causes of chronic obstructive
pulmonary disease (COPD). However, only a minority of smokers develop COPD. The …
pulmonary disease (COPD). However, only a minority of smokers develop COPD. The …
[HTML][HTML] Tensions in taxonomies: current understanding and future directions in the pathobiologic basis and treatment of group 1 and group 3 pulmonary hypertension
S Gu, K Goel, LM Forbes, VO Kheyfets… - Comprehensive …, 2023 - ncbi.nlm.nih.gov
In the over 100 years since the recognition of pulmonary hypertension (PH), immense
progress and significant achievements have been made with regard to understanding the …
progress and significant achievements have been made with regard to understanding the …
[HTML][HTML] Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension
K Zeder, LM Marsh, A Avian, L Brcic… - The Journal of Heart and …, 2024 - Elsevier
Background In patients with end-stage chronic obstructive pulmonary disease (COPD),
severe pulmonary hypertension (PH) is frequently associated with less severe airway …
severe pulmonary hypertension (PH) is frequently associated with less severe airway …
[HTML][HTML] Precision and advanced nano-phytopharmaceuticals for therapeutic applications
Phytopharmaceuticals have been widely used globally since ancient times and
acknowledged by healthcare professionals and patients for their superior therapeutic value …
acknowledged by healthcare professionals and patients for their superior therapeutic value …
[HTML][HTML] PD-1+ T lymphocyte proportions and hospitalized exacerbation of COPD: a prospective cohort study
H Xue, X Lan, T Xue, X Tang, H Yang, Z Hu, N Xu… - Respiratory …, 2024 - Springer
Objective To evaluate the predictive value of PD-1 expression in T lymphocytes for
rehospitalization due to acute exacerbations of COPD (AECOPD) in discharged patients …
rehospitalization due to acute exacerbations of COPD (AECOPD) in discharged patients …
[HTML][HTML] Fibroblast growth factor 10 reverses cigarette smoke-and elastase-induced emphysema and pulmonary hypertension in mice
Background COPD is an incurable disease and a leading cause of death worldwide. In
mice, fibroblast growth factor (FGF) 10 is essential for lung morphogenesis, and in humans …
mice, fibroblast growth factor (FGF) 10 is essential for lung morphogenesis, and in humans …
Cardiovascular disease and risk in COPD: a state of the art review
ABSTRACT Introduction Chronic Obstructive Pulmonary Disease (COPD) and
cardiovascular diseases (CVD) commonly co-exist. Outcomes of people living with both …
cardiovascular diseases (CVD) commonly co-exist. Outcomes of people living with both …
[HTML][HTML] Risk factors associated with pulmonary hypertension in patients with active tuberculosis and tuberculous destroyed lung: a retrospective study
W Liu, Y Xu, L Yang, S Zhan, K Pang, H Lin, H Qin… - Scientific Reports, 2024 - nature.com
Pulmonary tuberculosis (TB) can result in irreversible damage and lead to tuberculous
destructive lung (TDL), a severe chronic lung disease that is associated with a high mortality …
destructive lung (TDL), a severe chronic lung disease that is associated with a high mortality …
[PDF][PDF] 慢性阻塞性肺疾病急性加重期患者住院时间延长的危险因素分析
熊伟， 彭俊男， 王勤， 李兴龙， 王汉超， 朱涛 - 临床内科杂志, 2023 - lcnkzz.com
慢性阻塞性肺疾病急性加重期患者住院时间延长的危险因素分析 Page 1 [DOI]10.3969/j.issn.1001⁃9057.2023.09.007
http:/ /www.lcnkzz.com/CN/10.3969/j.issn.1001⁃9057.2023.09.007 ·论著· 慢性阻塞性肺疾病 …
http:/ /www.lcnkzz.com/CN/10.3969/j.issn.1001⁃9057.2023.09.007 ·论著· 慢性阻塞性肺疾病 …